Panacos Pharmaceuticals, Inc. (PANC)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 4, 2025
Panacos Pharmaceuticals Revenue
Panacos Pharmaceuticals had revenue of $24.00K in the quarter ending September 30, 2008, a decrease of -20.00%. This brings the company's revenue in the last twelve months to $99.00K, down -45.90% year-over-year. In the year 2007, Panacos Pharmaceuticals had annual revenue of $180.00K, down -36.62%.
Revenue (ttm)
99.00K
Revenue Growth
-45.90%
P/S Ratio
0.00
Revenue / Employee
2.41K
Employees
41
Market Cap
54.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 180.00K | -104.00K | -36.62% |
| Dec 31, 2006 | 284.00K | -765.00K | -72.93% |
| Dec 31, 2005 | 1.05M | -288.00K | -21.54% |
| Dec 31, 2004 | 1.34M | 259.00K | 24.03% |
| Dec 31, 2003 | 1.08M | 152.45K | 16.47% |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oriental Bioengineering | 121.58M |
| Genocea Biosciences | 1.91M |
| Baudax Bio | 1.27M |
| Mymetics | 564.14K |
| Cardax | 500.71K |
| Core One Labs | 338.91K |
| Bioasis Technologies | 199.01K |
| Athersys | 80.00K |